Ildong Pharmaceutical Co., Ltd. announced a private placement of series 2 unsecured convertible bonds for the gross proceeds of KRW 30,000,000,000 on October 18, 2023. The bonds will be 100% convertible into 1,628,045 common shares at a conversion price of KRW 18,427 per share. The transaction has been approved by the shareholders of the company and is expected to close on October 20, 2023.

The bonds will be matured on a debt maturity date of October 20, 2028. and have a maturity interest rate of 3%.